Semaglutide + Ipamorelin stack
A research-context overview of stacking Semaglutide with Ipamorelin: the rationale, complementary benefits, side-effect overlap, and pharmacokinetic considerations. Educational only — never a recommendation.
Why this stack?
Stacking a Metabolic agent (Semaglutide) with a Performance / GH-axis compound (Ipamorelin) is the canonical body-recomposition pattern: the GLP-1 / metabolic compound drives caloric deficit and visceral-fat reduction, while the GH-axis compound preserves lean mass and accelerates training-tissue repair under that deficit. Researchers running this pair typically titrate the metabolic agent up first, then layer the GH-axis compound once dose tolerance is established.
Semaglutide
The GLP-1 pioneer for sustainable weight loss and cardiovascular health.
Key benefits
- ✓Significant weight loss
- ✓Improved blood sugar control
- ✓Reduces heart attack/stroke risk
- ✓Strong appetite suppression
Side effects to watch
- ⚠Nausea
- ⚠Vomiting
- ⚠Diarrhea
Ipamorelin
Gentle GH releaser that amps muscle growth and fat loss without the harsh sides.
Key benefits
- ✓Increases lean muscle mass
- ✓Accelerates fat loss
- ✓Improves sleep quality
- ✓Enhances recovery
Side effects to watch
- ⚠Flushing
- ⚠Headache
- ⚠Lightheadedness
Half-life considerations
Semaglutide clears at roughly t½ 7 d, while Ipamorelin clears at roughly t½ 2.0 h. That is a wide PK separation: Semaglutide provides steady tonic exposure while Ipamorelin produces brief pulses on top. Schedule the short-acting compound around the timepoints where its acute effect is most useful.
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.